Hiroyuki Michiue

The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.

Koji Ono, Shinji Kawabata, Hideki Matsui, 2014, Biomaterials.

Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.

Hideki Matsui, Satoshi Kimura, Sayaka Watanabe, 2011, The Journal of clinical investigation.

Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).

Shiroh Futaki, Hideki Matsui, Ikuhiko Nakase, 2009, Journal of controlled release : official journal of the Controlled Release Society.